Characteristics and Treatment of New-Onset Arthritis After Checkpoint Inhibitor Therapy

RMD Open - United Kingdom
doi 10.1136/rmdopen-2018-000714
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Combination VEGFR/immune Checkpoint Inhibitor Therapy: A Promising New Treatment for Renal Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2018English

T-Cell Lymphoma Secondary to Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy

Case Reports in Oncological Medicine
Oncology
2017English

'Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation’ by Braaten Et Al: Another Point of View

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2020English

Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2020English

Clinical Characteristics and Treatment Responses in New-Onset Epilepsy in the Elderly

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2013English

FRI0037 Characteristics of Recent Elderly-Onset Rheumatoid Arthritis Patients

2018English

Complete Remission of Refractory Hodgkin’s Lymphoma in a Patient With AIDS After Single Dose Checkpoint Inhibitor Therapy

Journal of Case Reports and Images in Oncology
2020English

Early Basal Insulin Therapy Decreases New-Onset Diabetes After Renal Transplantation

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy